Clinical Trials Logo

Clinical Trial Details — Status: Completed

Administrative data

NCT number NCT03898115
Other study ID # Pro00101819
Secondary ID
Status Completed
Phase N/A
First received
Last updated
Start date May 1, 2019
Est. completion date September 30, 2020

Study information

Verified date February 2020
Source Duke University
Contact n/a
Is FDA regulated No
Health authority
Study type Interventional

Clinical Trial Summary

This study will be a multicenter, cluster randomized, step-wedged design. The unit of randomization will be the inpatient units admitted critically ill patients, with the interventions being carried out over 4 months. The study plans to enroll 14 units at 2 sites. Four sequences will be enrolled into the intervention each month; each sequence will have 3-4 units (see figure 1). Units eligible for the study will have patients that are critically ill admitted and have had at least 1 CLABSI events over the past 12 months (fiscal year). Given the pragmatic nature of the study design, there will be limited additional inclusion and exclusion criteria. Prior to the beginning the study, all nursing staff (RNs and nursing assistants [NAs]) will receive a survey link (RedCAP) to understand their perceptions of CHG bathing. After all units have been enrolled (approximately 4 months), nursing staff will be sent a post-survey to see if their perceptions have improved after the program. Further, the Context Assessment Index (used with permission; via RedCAP) will also be used to assess the context (i.e., culture) in which clinicians works and the effect this has on using evidence in practice. This will be provided to infection prevention champions on each unit one time, at the beginning of enrollment. All hospitals in the trial will receive access to site-level quality reports on CLABSI data. The interventions will include a "direct engagement" at the site level; this strategy will build upon current quality improvement interventions developed from the Agency for Healthcare Research & Quality for optimization of care for critically ill patients at risk for CLABSIs. The multidisciplinary teams will include national key opinion leaders in quality improvement working with local infection prevention specialists and support staff to help healthcare systems and hospitals design or revise quality improvement plans. Units will receive feedback on quality improvement efforts, including audit and feedback reviewing their CHG bathing compliance and CLABSI rates. Duke will serve as the primary statistical center and analysis will be generated by Duke. The only risk in this study is the possibility of breach of confidentiality. The primary objective of this study is to assess the effect of a customized, multifaceted quality improvement [QI] program on compliance with daily chlorhexidine gluconate (CHG) bathing per the AHRQ protocol in inpatient units that admit critically ill patients. Further, we will assess the effect of this program on nursing staffs' perception of the importance of CHG bathing. The Context Assessment Index (used with permission) will also be used to assess the context (i.e., culture) in which clinicians works and the effect this has on using evidence in practice. The secondary objective of this study is to examine the effect of the QI program on central line-associated bloodstream infection (CLABSI) rates. Primary outcomes and CLABSI rates will be measured at 12 months to assess sustainability.


Recruitment information / eligibility

Status Completed
Enrollment 14
Est. completion date September 30, 2020
Est. primary completion date October 31, 2019
Accepts healthy volunteers Accepts Healthy Volunteers
Gender All
Age group N/A and older
Eligibility Inclusion Criteria: - Units eligible for the study will have patients that are critically ill admitted and have had at least 1 CLABSI events over the past 12 months (fiscal year). Exclusion Criteria: - Units with 0 CLABSIs over the past 12 months (fiscal year).

Study Design


Related Conditions & MeSH terms

  • Central Line-associated Bloodstream Infection (CLABSI)
  • Sepsis

Intervention

Behavioral:
CHG Education
The CHG educational intervention will include "educational outreach" and "audit and feedback" implementation strategies

Locations

Country Name City State
United States Duke University Hospital Durham North Carolina
United States Wake Med Raleigh North Carolina

Sponsors (1)

Lead Sponsor Collaborator
Duke University

Country where clinical trial is conducted

United States, 

References & Publications (5)

Reynolds SS, Granger BB, Hatch D. Self-Reported versus observed audit: Measuring CHG bathing compliance. Am J Infect Control. 2021 Dec;49(12):1575-1577. doi: 10.1016/j.ajic.2021.08.019. Epub 2021 Aug 22. — View Citation

Reynolds SS, Woltz P, Keating E, Neff J, Elliott J, Granger BB. Program Evaluation of Implementation Science Outcomes From an Intervention to Improve Compliance With Chlorhexidine Gluconate Bathing: A Qualitative Study. Dimens Crit Care Nurs. 2022 Jul-Aug — View Citation

Reynolds SS, Woltz P, Keating E, Neff J, Elliott J, Hatch D, Yang Q, Granger BB. Results of the CHlorhexidine Gluconate Bathing implementation intervention to improve evidence-based nursing practices for prevention of central line associated bloodstream i — View Citation

Reynolds SS, Woltz P, Neff J, Elliott J, Granger BB. Impact of an Implementation Science Study on Nursing Leader Competencies: A Qualitative Study. Nurse Leader. 2022; 20(1): 70-74.

Woltz PC, Granger BB, Reynolds SS. Measuring and Evaluating Clinical Context in Implementation Science Research. AACN Adv Crit Care. 2022 Mar 15;33(1):103-110. doi: 10.4037/aacnacc2022664. — View Citation

Outcome

Type Measure Description Time frame Safety issue
Primary CHG Bathing Documentation Compliance (1) Compliance of daily CHG bathing documentation (measured via documentation audits) Span of 17 months total (initial intervention May - Oct. 2019; sustainability Sept. 2020)
Primary CHG Bathing Process Compliance (2) Compliance of CHG bathing process (measured via observational audits) Span of 17 months total (initial intervention May - Oct. 2019; sustainability Sept. 2020)
Secondary Unit Culture (3) Unit culture (measured via the Context Assessment Index) Pre (month 0); will be open for 2 weeks
Secondary Staff perceptions/knowledge of CHG bathing (4) Nursing staffs' perceptions of CHG bathing (measured via a Qualtrics pre- and post-survey of 24 total questions; 12 demographic and 12 related to CHG bathing) Pre (month 0) and post (170 weeks later)
Secondary CLABSIs (5) CLABSI rates (measured via current National Healthcare Safety Network [NHSN] processes) May 2019 - September 2020 (17 months total)
See also
  Status Clinical Trial Phase
Withdrawn NCT03282292 - Central Venous Catheter Insertion Site and Colonization in Pediatric Cardiac Surgery N/A
Recruiting NCT05740150 - Central Line-associated Bloodstream Infection Prevention Using TauroLock-Hep100 in Pediatric Oncology Patients. N/A
Recruiting NCT04548713 - CLiCK in the Critical Care Unit N/A
Completed NCT03253887 - Ethanol-lock Therapy for the Prevention of Non-tunneled Catheter-related Infection in Pediatric Patients Phase 3
Recruiting NCT06458231 - Determining the Prevalence of Primary and Secondary Central Line Associated Blood Stream Infection (CLABSI) at the Tertiary Care Hospital
Recruiting NCT05376566 - Hydrochloric Acid Lock Therapy for Central Line-associated Bloodstream Infections N/A
Not yet recruiting NCT04856878 - Effect of Vancomycin After Catheter Replacement Phase 4
Recruiting NCT01893060 - Umbilical Cord Care for the Prevention of Colonization N/A
Completed NCT00975923 - Safe Critical Care: Testing Improvement Strategies N/A
Enrolling by invitation NCT04559334 - Compassionate-Use of 4% T-EDTA Lock Solution for Central Venous Lines of Pediatric PN Patients N/A
Completed NCT05485051 - Daily Chlorexidine Bath for Health Care Associated Infection Prevention Phase 3
Completed NCT03692559 - The Effects of Different Ways of Dressing Central Line Associated Bloodstream Infections N/A
Completed NCT02969343 - Patient Safety Learning Laboratory: Making Acute Care More Patient-Centered N/A
Completed NCT03486093 - Port Protectors for Prevention of CLABSIs in Respiratory Semi-intensive Care Unit N/A
Completed NCT05919966 - The Association Between Chlorhexidine Bathing and Central Line-Associated Infections in Medical Intensive Care Units